Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Recurrent spontaneous coronary artery dissection: First case report in men with three episodes of spontaneous coronary dissection in separate vascular territories.

Papireddy MR, Nandish S, Mishkel GJ.

Catheter Cardiovasc Interv. 2016 Apr;87(5):E192-6. doi: 10.1002/ccd.26112. Epub 2015 Aug 7. Review.

PMID:
26252543
2.

Endovascular management of splenic artery aneurysms: case series using telescoping guide and cage/coil technique.

Darki A, Goswami NJ, Mishkel GJ.

Catheter Cardiovasc Interv. 2014 Dec 1;84(7):E65-70. doi: 10.1002/ccd.25268. Epub 2014 Aug 30.

PMID:
24155131
3.

One-year outcomes from an international study of the Ovation Abdominal Stent Graft System for endovascular aneurysm repair.

Mehta M, Valdés FE, Nolte T, Mishkel GJ, Jordan WD, Gray B, Eskandari MK, Botti C; A Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the Ovation Abdominal Stent Graft System Investigators.

J Vasc Surg. 2014 Jan;59(1):65-73.e1-3. doi: 10.1016/j.jvs.2013.06.065. Epub 2013 Aug 24.

4.

Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions.

Ormiston JA, Charles O, Mann T, Hall JJ, McGarry T, Cannon LA, Webster MW, Mishkel GJ, Underwood PL, Dawkins KD.

Coron Artery Dis. 2013 Jan;24(1):61-8. doi: 10.1097/MCA.0b013e32835b3932.

PMID:
23232250
5.

Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stents.

Kereiakes DJ, Cannon LA, Ormiston JA, Turco MA, Mann T, Mishkel GJ, McGarry T, Wang H, Underwood P, Dawkins KD.

Am J Cardiol. 2011 Sep 15;108(6):828-37. doi: 10.1016/j.amjcard.2011.05.011. Epub 2011 Jul 30.

PMID:
21803319
6.

ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians.

American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance, Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M, Ward RP, Weiner RB.

J Am Coll Cardiol. 2011 Mar 1;57(9):1126-66. doi: 10.1016/j.jacc.2010.11.002. No abstract available.

7.

ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians.

American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American College of Chest Physicians, Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M, Parker Ward R, Weiner RB.

J Am Soc Echocardiogr. 2011 Mar;24(3):229-67. doi: 10.1016/j.echo.2010.12.008.

PMID:
21338862
8.

A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial.

Cannon LA, Kereiakes DJ, Mann T, Popma JJ, Mooney MR, Mishkel GJ, Lee TC, Wilson BH, Stuckey TD, Orlow S, McGarry T, Ring ME, Kellett MA, Underwood P, Dawkins KD.

EuroIntervention. 2011 Mar;6(8):920-7, 1-2. doi: 10.4244/EIJV6I8A161.

9.

Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents.

Weissman NJ, Turco MA, Ormiston JA, Mann T, Cannon LA, McGarry TF, Webster MW, Hall JJ, Lucca MJ, Mishkel GJ, Wu CJ, Mandinov L, Dawkins KD.

Cardiovasc Revasc Med. 2011 Jul-Aug;12(4):247-57. doi: 10.1016/j.carrev.2010.09.008. Epub 2010 Dec 3.

PMID:
21130708
10.

Predictors of neurological events associated with carotid artery stenting in high-surgical-risk patients: insights from the Cordis Carotid Stent Collaborative.

Aronow HD, Gray WA, Ramee SR, Mishkel GJ, Schreiber TJ, Wang H.

Circ Cardiovasc Interv. 2010 Dec;3(6):577-84. doi: 10.1161/CIRCINTERVENTIONS.110.950097. Epub 2010 Nov 23.

11.

Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.

Goswami NJ, Gaffigan M, Berrio G, Plessa AL, Pfeiffer AM, Markwell SJ, Mishkel GJ.

Catheter Cardiovasc Interv. 2010 Jan 1;75(1):93-100. doi: 10.1002/ccd.22194.

PMID:
19787803
12.

Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.

Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MW, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS.

JACC Cardiovasc Interv. 2008 Dec;1(6):699-709. doi: 10.1016/j.jcin.2008.09.007.

13.

Correlates of late and very late thrombosis of drug eluting stents.

Mishkel GJ, Moore AL, Markwell S, Shelton ME.

Am Heart J. 2008 Jul;156(1):141-7. doi: 10.1016/j.ahj.2008.02.012. Epub 2008 May 5.

PMID:
18585509
14.

Long-term results of carotid stenting versus endarterectomy in high-risk patients.

Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Ansel G, Strickman NE, Wang H, Cohen SA, Massaro JM, Cutlip DE; SAPPHIRE Investigators.

N Engl J Med. 2008 Apr 10;358(15):1572-9. doi: 10.1056/NEJMoa0708028.

15.

Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease.

Mishkel GJ, Varghese JJ, Moore AL, Aguirre F, Markwell SJ, Shelton M.

J Invasive Cardiol. 2007 Aug;19(8):331-7.

16.

Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.

Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'Shaughnessy CD, Mann T, McGarry TF, Wu CJ, Chan C, Webster MW, Hall JJ, Mishkel GJ, Cannon LA, Baim DS, Koglin J.

J Am Coll Cardiol. 2007 Apr 24;49(16):1676-83. Epub 2007 Apr 6.

18.

Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents.

Mishkel GJ, Moore AL, Markwell S, Shelton MC, Shelton ME.

J Am Coll Cardiol. 2007 Jan 16;49(2):181-4. Epub 2006 Dec 29.

19.

Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).

Hirohata A, Morino Y, Ako J, Sakurai R, Buchbinder M, Caputo RP, Karas SP, Mishkel GJ, Mooney MR, O'shaughnessy CD, Raizner AE, Wilensky RL, Williams DO, Wong SC, Yock PG, Honda Y, Moses JW, Fitzgerald PJ; DIRECT Investigators.

Am J Cardiol. 2006 Dec 1;98(11):1464-7. Epub 2006 Oct 12.

PMID:
17126651
20.

Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).

Nikolsky E, Kosinski E, Mishkel GJ, Kimmelstiel C, McGarry TF Jr, Mehran R, Leon MB, Russell ME, Ellis SG, Stone GW.

Am J Cardiol. 2005 Mar 15;95(6):709-15.

PMID:
15757595

Supplemental Content

Loading ...
Support Center